Tuesday, November 13, 2012 11:34:43 PM
I received paperwork today (Form 14C) from Muscle Pharm stating that the Board of Directors authorized a R/S 1-for-850. This said to occur on or before Dec. 31, 2012. I have 4600 shares now and soon will have only 5 or 6 shares. That's a bummer.
After the R/S the company seeks to increase the A/S to 100 million shares. Currently A/S is 2.5 billion as of Oct. 25. The post R/S will reduce the number of shares of Common Stock issued to 2,697,254. Muscle Pharm is attempting to uplist to NASDAQ in the future which requires an initial bid price of $4.00 per share and a continued price of at least $1.00 per share. They also want to attract institutional investors.
-Jazz
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM